抄録
Tosufloxacin a new pyridone-carboxylic acid derivative, was used to treat 110 patients with otorhinolaryngological infections. They were 43 with otitis media, 38 with sinusitis and 29 with tonsillitis.
The clinical efficacy rate was assessed as excellent in 27 patients, good in 68 patients, fair in 13 patients and poor in 2 patients, the clinical efficacy rate being 85.5%. The bacterial examinations revealed an excellent eradication rate. No adverse events or abnormal laboratory finding were observed.
